Company intelligence / Profile preview
Civica Rx
- Ownership
- Private
- Development stage
- Other
Overview
Civica Rx is a nonprofit pharmaceutical company that manufactures and supplies over 70 essential generic medications to more than 1,400 U.S. hospitals. It has delivered over 210 million vials or syringes since its founding in 2018 and is expanding into affordable biosimilar insulin production. Its model has empirically improved drug supply security and reduced costs compared to traditional wholesalers[1][4][5].
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Civica Rx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Civica Rx.